58 results found.

Breast Cancer Clinical Trial using Nutrition Education; Acupuncture

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Comparison of Weight Loss Among Early Stage Breast Cancer Patients Post Chemotherapy: Nutrition Education in Combination With Weight Loss Acupuncture Vs. Nutrition Education Alone.
Nutrition Education; Acupuncture

Stage IB Breast Cancer, or Stage II Breast Cancer Clinical Trial using regional nodal XRT; chestwall XRT; WBI

National Surgical Adjuvant Breast and Bowel Project (NSABP) - Recruiting 18 years or older.
- A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy.
regional nodal XRT; chestwall XRT; WBI

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Ca Clinical Trial using fulvestrant; anastrozole

Alliance for Clinical Trials in Oncology - Recruiting 18 years or older.
- Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study.
fulvestrant; anastrozole

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Br Clinical Trial using laboratory biomarker analysis; pharmacological study; questionnaire administration; fluorine F 18-clevudine; positron emission tomography/computed tomography

University of Southern California - Recruiting 18 years or older.
- Development of an In Vivo Cell Proliferation Marker for PET Assessment of Chemotherapeutic Response in Cancer.
laboratory biomarker analysis; pharmacological study; questionnaire administration; fluorine F 18-clevudine; positron emission tomography/computed tomography

Invasive Ductal Carcinoma, or Ductal Carcinoma in Situ Clinical Trial using Intra-operative Radiation Therapy - IORT

Xoft, Inc. - Recruiting 40 years or older.
- A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoftr Axxentr eBxT System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer.
Intra-operative Radiation Therapy - IORT

Ductal Breast Carcinoma in Situ, Estrogen Receptor-negative Breas Clinical Trial using therapeutic conventional surgery; radiation therapy; quality-of-life assessment

Roswell Park Cancer Institute - Recruiting 50 years or older.
- Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer.
therapeutic conventional surgery; radiation therapy; quality-of-life assessment

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 50 years or older.
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer.
Proton Radiotherapy

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 18 years or older.
- Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Women With Stage III,Loco-Regional, Non-Metastatic Breast Cancer.
Proton Radiotherapy

Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma Clinical Trial using Behavioral dietary intervention; Therapeutic conventional surgery; Radiation therapy; Counseling intervention; Quality-of-life assessment

Thomas Jefferson University - Recruiting 18 years or older.
- A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients.
Behavioral dietary intervention; Therapeutic conventional surgery; Radiation therapy; Counseling intervention; Quality-of-life assessment

Breast Neoplasms, BRCA 1 Gene Mutation, or BRCA 2 Gene Mutation Clinical Trial using BMN 673

BioMarin Pharmaceutical - Recruiting 18 years or older.
- A Phase 2, 2-Stage, 2-Cohort Study of BMN 673 in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation.
BMN 673

Male Breast Cancer, Recurrent Breast Cancer, or Stage IV Breast C Clinical Trial using eribulin mesylate; laboratory biomarker analysis

University of Washington - Recruiting 18 years or older.
- Phase II Trial of Metronomic Eribulin (Halaven) In Pretreated Metastatic Breast Cancer (MBC).
eribulin mesylate; laboratory biomarker analysis

HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvan Clinical Trial using BKM120; Trastuzumab; Paclitaxel; Placebo

Novartis - Recruiting 18 years or older.
- NeoPHOEBE: Pi3k Inhibition in Her2 OverExpressing Breast cancEr: A Phase II, Randomized, Parallel Cohort, Two Stage, Double-blind, Placebo-controlled Study of Neoadjuvant Trastuzumab Versus Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive, PIK3CA Wild-type and PIK3CA Mutant Primary Breast Cancer.
BKM120; Trastuzumab; Paclitaxel; Placebo

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-posit Clinical Trial using zoledronic acid; laboratory biomarker analysis; therapeutic conventional surgery

City of Hope Medical Center - Recruiting N/A or older.
- A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer.
zoledronic acid; laboratory biomarker analysis; therapeutic conventional surgery

Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ Clinical Trial using docosahexaenoic acid; placebo; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.
docosahexaenoic acid; placebo; laboratory biomarker analysis

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Clinical Trial using cisplatin; laboratory biomarker analysis; pharmacological study; dynamic contrast-enhanced MRI, diffusion-weighted MRI & chemical exchange saturation transfer MRI; GDC -0941

Vanderbilt-Ingram Cancer Center - Recruiting 18 years or older.
- A Phase Ib/II Trial of GDC-0941 (a PI3K Inhibitor) in Combination With Cisplatin in Patients With Androgen Receptor Negative Triple Negative Metastatic Breast Cancer.
cisplatin; laboratory biomarker analysis; pharmacological study; dynamic contrast-enhanced MRI, diffusion-weighted MRI & chemical exchange saturation transfer MRI; GDC -0941

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Breast Clinical Trial using veliparib; carboplatin; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase II Trial of Single Agent ABT-888 With Post-Progression Therapy of ABT-888 in Combination With Carboplatin in Patients With Stage IV BRCA-associated Breast Cancer.
veliparib; carboplatin; laboratory biomarker analysis

Breast Cancer Clinical Trial using One-stage dermal matrix/implant procedure; Two-stage tissue expander/implant procedure

University Health Network, Toronto - Recruiting 18 years to 75 years.
- Acellular Dermal Matrix in One-Stage Breast Reconstruction: A RCT.
One-stage dermal matrix/implant procedure; Two-stage tissue expander/implant procedure

Male Breast Cancer, Recurrent Breast Cancer, or Stage IV Breast C Clinical Trial using paclitaxel albumin-stabilized nanoparticle formulation; questionnaire administration

City of Hope Medical Center - Recruiting 65 years or older.
- Efficacy and Tolerability of Nanoparticle Albumin Bound Paclitaxel (Abraxane) in Patients 65 and Older With Metastatic Breast Cancer.
paclitaxel albumin-stabilized nanoparticle formulation; questionnaire administration

Breast Cancer Clinical Trial using palliative surgery; therapeutic conventional surgery; palliative radiation therapy; radiation therapy

Eastern Cooperative Oncology Group - Recruiting 18 years or older.
- A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients With Metastatic Breast Cancer.
palliative surgery; therapeutic conventional surgery; palliative radiation therapy; radiation therapy

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complic Clinical Trial using anastrozole; questionnaire administration; laboratory biomarker analysis; pharmacogenomic studies

Eastern Cooperative Oncology Group - Recruiting 18 years or older.
- A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS).
anastrozole; questionnaire administration; laboratory biomarker analysis; pharmacogenomic studies

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Clinical Trial using questionnaire administration; quality-of-life assessment; management of therapy complications; exercise intervention

University of Southern California - Recruiting 18 years or older.
- Combined Exercise Program for Early Breast Cancer Survivors.
questionnaire administration; quality-of-life assessment; management of therapy complications; exercise intervention

Stage I Breast Carcinoma, or Stage II Breast Carcinoma Clinical Trial using intra-operative MRI

Dana-Farber Cancer Institute - Recruiting 18 years to 75 years.
- A Pilot Study to Evaluate Image-guided Breast Conserving Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO).
intra-operative MRI

Stage 0/1 Breast Cancer, Post Biopsy, or Pre-surgery Clinical Trial using IV/oral n-acetylcysteine

Thomas Jefferson University - Recruiting 18 years or older.
- Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer.
IV/oral n-acetylcysteine

Early Stage Breast Cancer Clinical Trial using Melatonin; Vitamin D; Placebo (melatonin); Placebo (vitamin D)

Juravinski Cancer Center - Recruiting 18 years or older.
- Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer.
Melatonin; Vitamin D; Placebo (melatonin); Placebo (vitamin D)

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer, S Clinical Trial using propranolol hydrochloride; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Pilot Study of Beta-Blockers in Patients With Advanced Cancer.
propranolol hydrochloride; Correlative Studies

Male Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Clinical Trial using mifepristone; carboplatin; gemcitabine hydrochloride; laboratory biomarker analysis; pharmacological study

University of Chicago - Recruiting 18 years or older.
- Carboplatin, Gemcitabine, and Mifepristone for Advanced Breast Cancer and Recurrent or Persistent Epithelial Ovarian Cancer.
mifepristone; carboplatin; gemcitabine hydrochloride; laboratory biomarker analysis; pharmacological study

HER2-positive Breast Cancer, or TNM Stage II-IV Breast Cancer Clinical Trial

ICORG- All Ireland Cooperative Oncology Research Group - Recruiting N/A or older.
- CharactHer: A Study of the Molecular and Cytogenetic Characteristics of HER2-positive Breast Cancers to Predict Durable Complete Response After Chemotherapy and Trastuzumab.

HER2-positive Breast Cancer, Recurrent Breast Cancer, or Stage IV Clinical Trial using pertuzumab; trastuzumab; paclitaxel albumin-stabilized nanoparticle formulation; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 19 years or older.
- Phase II Prospective Open Label Single Arm Study of Pertuzumab, Trastuzumab, and Nab-Paclitaxel in Patients With HER-2 Positive Metastatic Breast Cancer.
pertuzumab; trastuzumab; paclitaxel albumin-stabilized nanoparticle formulation; laboratory biomarker analysis

Weight Clinical Trial using Diet and exercise

Baptist Health South Florida - Recruiting 18 years to 89 years.
- A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer.
Diet and exercise

HER2-positive Breast Cancer, Inflammatory Breast Cancer, Male Bre Clinical Trial using entinostat; lapatinib ditosylate; trastuzumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I and Phase I Trastuzumab Cohort Study of Entinostat, Lapatinib and Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer in Whom Trastuzumab Has Failed.
entinostat; lapatinib ditosylate; trastuzumab; laboratory biomarker analysis

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Ca Clinical Trial using docetaxel; carboplatin; trastuzumab; pertuzumab; goserelin acetate; therapeutic conventional surgery; whole breast irradiation; quality-of-life assessment; laboratory biomarker analysis; aromatase inhibition therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients With Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated With Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) With or Without Estrogen Deprivation.
docetaxel; carboplatin; trastuzumab; pertuzumab; goserelin acetate; therapeutic conventional surgery; whole breast irradiation; quality-of-life assessment; laboratory biomarker analysis; aromatase inhibition therapy

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Ca Clinical Trial using systemic chemotherapy; tamoxifen citrate; anastrozole; exemestane; letrozole

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A PHASE III, RANDOMIZED CLINICAL TRIAL OF STANDARD ADJUVANT ENDOCRINE THERAPY +/-CHEMOTHERAPY IN PATIENTS WITH 1-3 POSITIVE NODES, HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCER WITH RECURRENCE SCORE (RS) OF 25 OR LESS. RXPONDER: A CLINICAL TRIAL RX FOR POSITIVE NODE, ENDOCRINE RESPONSIVE BREAST CANCER.
systemic chemotherapy; tamoxifen citrate; anastrozole; exemestane; letrozole

Male Breast Cancer, Neurotoxicity, Peripheral Neuropathy, Stage I Clinical Trial using laboratory biomarker analysis; questionnaire administration

Fox Chase Cancer Center - Recruiting 18 years or older.
- Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy.
laboratory biomarker analysis; questionnaire administration

Estrogen Receptor-positive Breast Cancer, Stage I Breast Cancer, Clinical Trial using tamoxifen citrate; polymerase chain reaction; pharmacological study; gene expression analysis; immunohistochemistry staining method; pharmacogenomic studies; matrix-assisted laser desorption/ionization time of flight mass spectrometry; polymorphism analysis; therapeutic conventional surgery; nucleic acid sequencing; protein analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Pilot Study to Analyze a Novel Mechanism Underlying Response to Tamoxifen Therapy in Breast Cancer Patients.
tamoxifen citrate; polymerase chain reaction; pharmacological study; gene expression analysis; immunohistochemistry staining method; pharmacogenomic studies; matrix-assisted laser desorption/ionization time of flight mass spectrometry; polymorphism analysis; therapeutic conventional surgery; nucleic acid sequencing; protein analysis

Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ, Lo Clinical Trial using educational intervention; counseling intervention; psychosocial support for caregiver; questionnaire administration; laboratory biomarker analysis

University of Washington - Recruiting N/A or older.
- Psychoeducation for Spouses/Partners of Women With Breast Cancer.
educational intervention; counseling intervention; psychosocial support for caregiver; questionnaire administration; laboratory biomarker analysis

Triple Negative Breast Cancer Clinical Trial using Veliparib; Carboplatin; Paclitaxel; Doxorubicin; Cyclophosphamide

AbbVie - Recruiting 18 years or older.
- A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer (TNBC).
Veliparib; Carboplatin; Paclitaxel; Doxorubicin; Cyclophosphamide

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Ca Clinical Trial using Paclitaxel; Carboplatin; Doxorubicin; Cyclophosphamide; Veliparib

Thomas Jefferson University - Recruiting 18 years or older.
- An Adaptive, Randomized Phase II Trial to Determine Pathologic Complete Response With the Addition of Carboplatin With and Without Veliparib to Standard Chemotherapy in the Neoadjuvant Treatment of Triple-Negative Breast Cancer.
Paclitaxel; Carboplatin; Doxorubicin; Cyclophosphamide; Veliparib

Breast Cancer, or Stage IV Breast Cancer Clinical Trial using positron emission tomography; copper Cu 64-DOTA-trastuzumab; Biopsy; Immunohistochemistry staining method; laboratory biomarker analysis; mutation analysis

City of Hope Medical Center - Recruiting 18 years or older.
- 64 Cu-DOTA-Trastuzumab Positron Emission Tomography in Women With Advanced HER2 Positive Invasive Breast Cancer.
positron emission tomography; copper Cu 64-DOTA-trastuzumab; Biopsy; Immunohistochemistry staining method; laboratory biomarker analysis; mutation analysis

Breast Cancer Clinical Trial using Lapatinib; Trastuzumab; Endocrine Therapy; Paclitaxel

SOLTI Breast Cancer Research Group - Recruiting 18 years or older.
- PAMELA: PAM50 HER2-enriched Phenotype as a Predictor of Early Response to Neoadjuvant Lapatinib Plus Trastuzumab in Stage I to IIIA HER2-positive Breast Cancer.
Lapatinib; Trastuzumab; Endocrine Therapy; Paclitaxel

Breast Neoplasms Clinical Trial using Doxorubicin; Trastuzumab; Cyclophosphamide; Paclitaxel

Washington University School of Medicine - Recruiting 18 years or older.
- A Phase II Randomized Trial Evaluating the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Bone Marrow Disseminated Tumor Cells.
Doxorubicin; Trastuzumab; Cyclophosphamide; Paclitaxel

Breast Cancer Clinical Trial using 9 Peptides from Her-2/neu, CEA, & CTA + poly-ICLC

University of Virginia - Recruiting 18 years or older.
- A Pilot Study of the Immunogenicity of a 9-Peptide Breast Cancer Vaccine Plus Poly-ICLC in Stage IB-IIIA Breast Cancer.
9 Peptides from Her-2/neu, CEA, & CTA + poly-ICLC

Early Stage Breast Cancer Clinical Trial using Stereotactic Body Radiation Therapy

University of Texas Southwestern Medical Center - Recruiting 18 years or older.
- A Phase I Study of Cyberknifer Partial Breast Irradiation (PBI) for Early Stage Breast Cancer.
Stereotactic Body Radiation Therapy

Breast Cancer Clinical Trial using Paclitaxel; Eribulin; 5-Fluorouracil; Epirubicin; Cyclophosphamide; Doxorubicin

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Randomized Phase II Neoadjuvant Study of Sequential Eribulin Followed by FAC/FEC-regimen Compared to Sequential Paclitaxel Followed by FAC/FEC-Regimen in Women With Early Stage Breast Cancer Not Overexpressing HER-2.
Paclitaxel; Eribulin; 5-Fluorouracil; Epirubicin; Cyclophosphamide; Doxorubicin

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Ca Clinical Trial using dinaciclib; epirubicin hydrochloride; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 1 Study With Dose Expansion of Dinaciclib (SCH 727965) in Combination With Epirubicin in Patients With Metastatic Triple Negative Breast Cancer.
dinaciclib; epirubicin hydrochloride; laboratory biomarker analysis

Carcinoma Breast Stage I, or HER2 Positive Breast Cancer Clinical Trial using Trastuzumab; Placebo

Tata Memorial Hospital - Recruiting 18 years or older.
- A Phase III Double Blind Randomized Placebo Controlled Study of Trastuzumab as Short Duration Preoperative Therapy in Patients With HER2-neu Positive Operable Breast Cancer.
Trastuzumab; Placebo

Breast Cancer Clinical Trial using Tumor Biopsy; Breast Cancer Registry

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Feasibility, Validation and Implementation of Genomic Testing for Chemotherapy and Endocrine Sensitivity of HER2 Negative Primary Invasive Breast Cancer (Clinical Stage I to III).
Tumor Biopsy; Breast Cancer Registry

Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Can Clinical Trial using Tamoxifen; Breast cancer surgery

University of Utah - Recruiting 18 years or older.
- Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance.
Tamoxifen; Breast cancer surgery

Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Brea Clinical Trial using paclitaxel; trastuzumab; doxorubicin hydrochloride; cyclophosphamide; laboratory biomarker analysis; cytology specimen collection procedure

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy.
paclitaxel; trastuzumab; doxorubicin hydrochloride; cyclophosphamide; laboratory biomarker analysis; cytology specimen collection procedure

Early Stage Breast Cancer Clinical Trial

Summa Health System - Recruiting 18 years to 85 years.
- Evaluation of Breast Magnetic Resonance Imaging (MRI) Impact on Mastectomy Rate at Summa Akron City Hospital.

Breast Cancer, or Early Stage Clinical Trial using Proton Beam Radiotherapy

Loma Linda University - Recruiting 40 years to 80 years.
- Phase 2 Trial of Partial Breast Proton Therapy for Early Stage Breast Cancer With Low and Intermediate Risk Factors..
Proton Beam Radiotherapy

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-p Clinical Trial using therapeutic estradiol; exemestane; laboratory biomarker analysis; enzyme-linked immunosorbent assay

University of Arizona - Recruiting N/A or older.
- A Pilot Study Of Estradiol Followed By Exemestane For Post-Menopausal Hormone Receptor Positive Metastatic Breast Cancer After Prior Failed Endocrine Therapy: Reversing Endocrine Resistance.
therapeutic estradiol; exemestane; laboratory biomarker analysis; enzyme-linked immunosorbent assay

Breast Cancer Clinical Trial using 3-dimensional conformal accelerated partial breast irradiation; brachytherapy; whole breast irradiation

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer.
3-dimensional conformal accelerated partial breast irradiation; brachytherapy; whole breast irradiation

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Ca Clinical Trial using mifepristone; placebo; nab-paclitaxel

University of Chicago - Recruiting 18 years or older.
- A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer.
mifepristone; placebo; nab-paclitaxel

Breast Cancer Clinical Trial using trastuzumab; parenteral chemotherapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve.
trastuzumab; parenteral chemotherapy

Breast Lesions, Breast Cyst, Early-Stage Breast Cancer, or Benign Clinical Trial

Spectros Corporation - Recruiting 21 years to 50 years.
- Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning.

Breast Cancer, Depression, Long-term Effects of Cancer Treatment, Clinical Trial using educational intervention; informational intervention; internet-based intervention; questionnaire administration; study of socioeconomic and demographic variables; survey administration; psychosocial assessment and care; quality-of-life assessment

National Cancer Institute (NCI) - Recruiting N/A or older.
- Cancer Information Service Research Consortium: Years 2006-2011 Program Narrative and Overview.
educational intervention; informational intervention; internet-based intervention; questionnaire administration; study of socioeconomic and demographic variables; survey administration; psychosocial assessment and care; quality-of-life assessment

Breast Cancer Clinical Trial using capecitabine; paclitaxel albumin-stabilized nanoparticle formulation; neoadjuvant therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Combination Capecitabine (Xeloda) and ABI-007 (Abraxane, Nanoparticle Albumin-Bound Paclitaxel) Chemotherapy as Neoadjuvant Treatment of Locally Advanced, Operable Breast Cancer.
capecitabine; paclitaxel albumin-stabilized nanoparticle formulation; neoadjuvant therapy

Breast Neoplasms Clinical Trial using Docetaxel; Capecitabine; Docetaxel/Capecitabine

Georgia Center for Oncology Research & Education - Recruiting 18 years or older.
- Randomized Phase II Trial of Sequential Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine as in Induction Therapy for Early Stage Breast Cancer.
Docetaxel; Capecitabine; Docetaxel/Capecitabine